HC-030031
- Generic Name
- HC-030031
A Study of LY3526318 in Healthy Male Japanese Participants
- Conditions
- Healthy
- Interventions
- First Posted Date
- 2022-10-14
- Last Posted Date
- 2023-01-09
- Lead Sponsor
- Eli Lilly and Company
- Registration Number
- NCT05580250
- Locations
- π―π΅
Souseikai Fukuoka Mirai Hospital, Fukuoka, Japan
Chronic Pain Master Protocol (CPMP): A Study of LY3526318 in Participants With Diabetic Peripheral Neuropathic Pain
- Conditions
- Diabetic Peripheral Neuropathic Pain
- Interventions
- Drug: Placebo
- First Posted Date
- 2022-01-04
- Last Posted Date
- 2023-11-22
- Lead Sponsor
- Eli Lilly and Company
- Target Recruit Count
- 155
- Registration Number
- NCT05177094
- Locations
- πΊπΈ
Synexus Clinical Research US, Inc - Orlando, The Villages, Florida, United States
πΊπΈNorthwest Clinical Research Center, Bellevue, Washington, United States
πΊπΈRainier Clinical Research Center, Renton, Washington, United States
Chronic Pain Master Protocol (CPMP): A Study of LY3526318 in Participants With Chronic Low Back Pain
- First Posted Date
- 2021-10-20
- Last Posted Date
- 2023-10-05
- Lead Sponsor
- Eli Lilly and Company
- Target Recruit Count
- 159
- Registration Number
- NCT05086289
- Locations
- πΊπΈ
VIN-Julie Schwartzbard, Aventura, Florida, United States
πΊπΈSuncoast Research Group, Miami, Florida, United States
πΊπΈNew Horizon Research Center, Miami, Florida, United States
Chronic Pain Master Protocol (CPMP): A Study of LY3526318 in Participants With Osteoarthritis
- Conditions
- OsteoarthritisOsteo Arthritis Knee
- Interventions
- Drug: Placebo
- First Posted Date
- 2021-10-18
- Last Posted Date
- 2024-07-17
- Lead Sponsor
- Eli Lilly and Company
- Target Recruit Count
- 160
- Registration Number
- NCT05080660
- Locations
- πΊπΈ
Alliance for Multispecialty Research, LLC Tempe, Tempe, Arizona, United States
πΊπΈClinvest Research LLC, Springfield, Missouri, United States
πΊπΈArtemis Institute for Clinical Research, San Diego, California, United States
A Safety Study of LY3526318 in Healthy Participants
- First Posted Date
- 2020-12-23
- Last Posted Date
- 2021-06-10
- Lead Sponsor
- Eli Lilly and Company
- Target Recruit Count
- 16
- Registration Number
- NCT04682119
- Locations
- π³π±
PRA Health Sciences, Groningen, Netherlands
A Study of LY3526318 in Healthy Women
- First Posted Date
- 2019-12-03
- Last Posted Date
- 2020-03-17
- Lead Sponsor
- Eli Lilly and Company
- Target Recruit Count
- 16
- Registration Number
- NCT04183283
- Locations
- π§πͺ
Universitaire Ziekenhuizen Leuven - Campus Gasthuisberg, Leuven, Belgium
A Study of LY3526318 in Healthy Participants
- First Posted Date
- 2019-06-06
- Last Posted Date
- 2020-04-22
- Lead Sponsor
- Eli Lilly and Company
- Target Recruit Count
- 76
- Registration Number
- NCT03977974
- Locations
- π³π±
PRA Health Sciences, Groningen, Netherlands
Drug Development Updates
Stay informed with timely notifications on clinical trials, regulatory changes, and research advancements related to this medication.